Literature DB >> 11784789

Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis.

Kunihiro Uryu1, Helmut Laurer, Tracy McIntosh, Domenico Praticò, Daniel Martinez, Susan Leight, Virginia M-Y Lee, John Q Trojanowski.   

Abstract

Traumatic brain injury (TBI) increases susceptibility to Alzheimer's disease (AD), but it is not known how TBI contributes to the onset or progression of this common late life dementia. To address this question, we studied neuropathological and behavioral consequences of single versus repetitive mild TBI (mTBI) in transgenic (Tg) mice (Tg2576) that express mutant human Abeta precursor protein, and we demonstrate elevated brain Abeta levels and increased Abeta deposition. Nine-month-old Tg2576 and wild-type mice were subjected to single (n = 15) or repetitive (n = 39) mTBI or sham treatment (n = 37). At 2 d and 9 and 16 weeks after treatment, we assessed brain Abeta deposits and levels in addition to brain and urine isoprostanes generated by lipid peroxidation in these mice. A subset of mice also was studied behaviorally at 16 weeks after injury. Repetitive but not single mTBI increased Abeta deposition as well as levels of Abeta and isoprostanes only in Tg mice, and repetitive mTBI alone induced cognitive impairments but no motor deficits in these mice. This is the first experimental evidence linking TBI to mechanisms of AD by showing that repetitive TBI accelerates brain Abeta accumulation and oxidative stress, which we suggest could work synergistically to promote the onset or drive the progression of AD. Additional insights into the role of TBI in mechanisms of AD pathobiology could lead to strategies for reducing the risk of AD associated with previous episodes of brain trauma and for preventing progressive brain amyloidosis in AD patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11784789      PMCID: PMC6758680     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  59 in total

1.  Down's syndrome is associated with increased 8,12-iso-iPF2alpha-VI levels: evidence for enhanced lipid peroxidation in vivo.

Authors:  D Praticò; L Iuliano; G Amerio; L X Tang; J Rokach; G Sabatino; F Violi
Journal:  Ann Neurol       Date:  2000-11       Impact factor: 10.422

2.  Accelerated accumulation of amyloid beta proteins on oxidatively damaged lipid membranes.

Authors:  V Koppaka; P H Axelsen
Journal:  Biochemistry       Date:  2000-08-15       Impact factor: 3.162

3.  Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease.

Authors:  G W Roberts; S M Gentleman; A Lynch; L Murray; M Landon; D I Graham
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

4.  Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity.

Authors:  D Praticò; C M Clark; V M Lee; J Q Trojanowski; J Rokach; G A FitzGerald
Journal:  Ann Neurol       Date:  2000-11       Impact factor: 10.422

Review 5.  Oxidative alterations in Alzheimer's disease.

Authors:  W R Markesbery; J M Carney
Journal:  Brain Pathol       Date:  1999-01       Impact factor: 6.508

6.  The amino acid sequence of neuritic plaque amyloid from a familial Alzheimer's disease patient.

Authors:  T Wisniewski; M Lalowski; E Levy; M R Marques; B Frangione
Journal:  Ann Neurol       Date:  1994-02       Impact factor: 10.422

7.  An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

Authors:  N Suzuki; T T Cheung; X D Cai; A Odaka; L Otvos; C Eckman; T E Golde; S G Younkin
Journal:  Science       Date:  1994-05-27       Impact factor: 47.728

8.  Alzheimer's disease: a study of epidemiological aspects.

Authors:  A Heyman; W E Wilkinson; J A Stafford; M J Helms; A H Sigmon; T Weinberg
Journal:  Ann Neurol       Date:  1984-04       Impact factor: 10.422

9.  Altered cleavage and secretion of a recombinant beta-APP bearing the Swedish familial Alzheimer's disease mutation.

Authors:  K M Felsenstein; L W Hunihan; S B Roberts
Journal:  Nat Genet       Date:  1994-03       Impact factor: 38.330

10.  Head injury as a risk factor for Alzheimer's disease.

Authors:  J A Mortimer; L R French; J T Hutton; L M Schuman
Journal:  Neurology       Date:  1985-02       Impact factor: 9.910

View more
  112 in total

1.  A mouse model of human repetitive mild traumatic brain injury.

Authors:  Michael J Kane; Mariana Angoa-Pérez; Denise I Briggs; David C Viano; Christian W Kreipke; Donald M Kuhn
Journal:  J Neurosci Methods       Date:  2011-09-12       Impact factor: 2.390

2.  Preserved fronto-striatal plasticity and enhanced procedural learning in a transgenic mouse model of Alzheimer's disease overexpressing mutant hAPPswe.

Authors:  Silvia Middei; Raffaella Geracitano; Antonio Caprioli; Nicola Mercuri; Martine Ammassari-Teule
Journal:  Learn Mem       Date:  2004 Jul-Aug       Impact factor: 2.460

Review 3.  Metabolic reserve as a determinant of cognitive aging.

Authors:  Alexis M Stranahan; Mark P Mattson
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

4.  Therapeutic effect of SN50, an inhibitor of nuclear factor-κB, in treatment of TBI in mice.

Authors:  Yu-Xia Sun; Ding-Kun Dai; Ran Liu; Tao Wang; Cheng-Liang Luo; Hai-Jun Bao; Rui Yang; Xue-Ying Feng; Zheng-Hong Qin; Xi-Ping Chen; Lu-Yang Tao
Journal:  Neurol Sci       Date:  2012-03-23       Impact factor: 3.307

Review 5.  Dementia resulting from traumatic brain injury: what is the pathology?

Authors:  Sharon Shively; Ann I Scher; Daniel P Perl; Ramon Diaz-Arrastia
Journal:  Arch Neurol       Date:  2012-10

6.  5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer's disease.

Authors:  Omidreza Firuzi; Jiamin Zhuo; Cinzia M Chinnici; Thomas Wisniewski; Domenico Praticò
Journal:  FASEB J       Date:  2007-11-12       Impact factor: 5.191

7.  Modulation of nuclear factor-kappa B activity by indomethacin influences A beta levels but not A beta precursor protein metabolism in a model of Alzheimer's disease.

Authors:  Syaun Sung; Hengxuan Yang; Kunihiro Uryu; Edward B Lee; Lei Zhao; Diana Shineman; John Q Trojanowski; Virginia M-Y Lee; Domenico Praticò
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

8.  Inducible nitric oxide synthase in long-term intermittent hypoxia: hypersomnolence and brain injury.

Authors:  Guanxia Zhan; Polina Fenik; Domenico Pratico; Sigrid C Veasey
Journal:  Am J Respir Crit Care Med       Date:  2005-03-04       Impact factor: 21.405

9.  BRAIN MYELINATION IN PREVALENT NEUROPSYCHIATRIC DEVELOPMENTAL DISORDERS: PRIMARY AND COMORBID ADDICTION.

Authors:  George Bartzokis
Journal:  Adolesc Psychiatry       Date:  2005

10.  Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury.

Authors:  Annika Olsson; Ludvig Csajbok; Martin Ost; Kina Höglund; Karin Nylén; Lars Rosengren; Bengt Nellgård; Kaj Blennow
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.